Lophius Biosciences Overview

  • Founded
  • 2002
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 14
Employees
  • Latest Deal Type
  • M&A

Lophius Biosciences General Information

Description

Developer of immune diagnostic systems designed to transform treatment paradigms and patient management with molecular diagnostics. The company's systems facilitate an efficient stimulation of a broad spectrum of clinically-relevant immune effector cells to accurately measure the cell-mediated immunity, enabling physicians to differentiate between active T-cells versus T-memory cells and identify patients with a contagious active disease and latent infection.

Contact Information

Website
www.lophius.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Other Devices and Supplies
Discovery Tools (Healthcare)
Parent Company
Mikrogen
Primary Office
  • Am BioPark 13
  • 93053 Regensburg
  • Germany
+49 0941 00000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lophius Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 08-Mar-2021 0000 Completed Generating Revenue
11. Later Stage VC 19-Sep-2019 00.000 0000 000.00 Completed Generating Revenue
10. Grant 31-May-2017 00.000 000.00 Completed Generating Revenue
9. Later Stage VC 16-Mar-2017 00.000 000.00 000.00 Completed Generating Revenue
8. Later Stage VC 01-Jul-2016 00.000 000.00 000.00 Completed Generating Revenue
7. Grant 28-Oct-2015 000.00 00.000 Completed Generating Revenue
6. Later Stage VC 10-Sep-2015 00.000 Completed Generating Revenue
5. Later Stage VC 08-May-2014 00.000 00.000 000.00 Completed Generating Revenue
4. Later Stage VC 22-Jan-2013 $5.22M Completed Generating Revenue
3. Later Stage VC 18-Jul-2011 $2.29M $5.22M 00.000 Completed Generating Revenue
To view Lophius Biosciences’s complete valuation and funding history, request access »

Lophius Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of immune diagnostic systems designed to transform treatment paradigms and patient management with molecular d
Diagnostic Equipment
Regensburg, Germany
14 As of 2021
0000
000000&0 0000

0000000

a commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu
0000000000 000000000
Regensburg, Germany
00 As of 0000
000.00
0000 0000-00-00
0000000000 0 000.00

00000000

amco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volu
0000 000000000
Berlin, Germany
00 As of 0000
00000
0000000000 0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lophius Biosciences Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
numares Venture Capital-Backed Regensburg, Germany 00 000.00 0000000000 0 000.00
000000000 Venture Capital-Backed Berlin, Germany 00 00000 0000000000 0 00000
00000000 Venture Capital-Backed Heidelberg, Germany 00 000.00 0000000000 000.00
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
000000000 Formerly VC-backed Vancouver, Canada 000 00000 000000 - 000 00000
To view Lophius Biosciences’s complete competitors history, request access »

Lophius Biosciences Executive Team (8)

Name Title Board Seat Contact Info
Bernd Merkl Chief Executive Officer & Managing Director
Ludwig Deml Ph.D Co-Founder & Chief Scientific Officer
You’re viewing 2 of 8 executive team members. Get the full list »

Lophius Biosciences Board Members (8)

Name Representing Role Since
Manfred Baier Ph.D Lophius Biosciences Board Member 000 0000
Monika Steger Bayern Kapital Board Member 000 0000
Ralf Wagner Ph.D Self Chairman 000 0000
Robert Silverman Self Board Member 000 0000
Stefan Beil Ph.D Sobera Capital Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Lophius Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lophius Biosciences Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bayern Kapital Venture Capital Minority 000 0000 000000 0
Bundesministerium für Bildung und Forschung Government 000 0000 000000 0
Heidelberg Innovation Fonds Management Venture Capital Minority 000 0000 000000 0
High-Tech Gründerfonds Venture Capital Minority 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »